Tilray Brands (NASDAQ:TLRY) Trading 1.8% Higher – Here’s Why

Tilray Brands, Inc. (NASDAQ:TLRY) traded up 1.8% during mid-day trading on Wednesday . The stock traded as high as $5.69 and last traded at $5.55. 3,288,637 shares traded hands during trading, a decline of 25% from the average session volume of 4,411,596 shares. The stock had previously closed at $5.45.

Tilray Brands News Roundup

Here are the key news stories impacting Tilray Brands this week:

• Positive Sentiment: Tilray’s BrewDog brand launched a broad summer “Underdog” marketing campaign in the U.K., including retail promotions, bar activations, digital media, a “Win a Year of Beer” contest, and watch parties, which could help support beverage sales and brand visibility. Article Title
• Positive Sentiment: Tilray Medical highlighted its presence at Cannabis Europa London 2026, reinforcing the company’s international medical-cannabis expertise and its focus on patient access and regulatory discussions. Article Title
• Neutral Sentiment: Several commentary pieces note that Tilray’s fundamentals have improved somewhat, but the stock still hinges heavily on potential U.S. marijuana rescheduling or other federal regulatory changes to drive a sustained move higher. Article Title
• Neutral Sentiment: Another market commentary says Tilray looks positioned for a breakout only if a key catalyst materializes, again emphasizing that regulation rather than operating momentum is likely to matter most for the stock. Article Title
• Negative Sentiment: Recent coverage also stresses that TLRY has fallen sharply this year and remains near multi-month lows, reflecting ongoing investor concern about the company’s weak share performance and limited near-term catalysts. Article Title

Analyst Upgrades and Downgrades

Several analysts have weighed in on the company. TD Cowen dropped their price objective on Tilray Brands from $10.00 to $7.00 and set a “buy” rating for the company in a report on Monday, March 30th. Wall Street Zen raised Tilray Brands from a “sell” rating to a “hold” rating in a report on Saturday, March 21st. Roth Mkm raised Tilray Brands from a “neutral” rating to a “buy” rating and set a $10.00 price objective for the company in a report on Thursday, April 2nd. Zacks Research raised Tilray Brands from a “strong sell” rating to a “hold” rating in a report on Wednesday, February 11th. Finally, Weiss Ratings cut Tilray Brands from a “sell (d-)” rating to a “sell (e+)” rating in a report on Wednesday, May 13th. Three research analysts have rated the stock with a Buy rating, four have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, Tilray Brands presently has a consensus rating of “Hold” and a consensus target price of $11.50.

Tilray Brands Trading Up 1.8%

The company has a current ratio of 2.79, a quick ratio of 1.66 and a debt-to-equity ratio of 0.19. The company has a market capitalization of $646.85 million, a P/E ratio of -0.41 and a beta of 1.94. The business has a 50 day moving average price of $6.28 and a 200 day moving average price of $8.02.

Tilray Brands (NASDAQ:TLRY) last announced its quarterly earnings results on Wednesday, April 1st. The company reported ($0.24) EPS for the quarter, missing analysts’ consensus estimates of ($0.14) by ($0.10). The company had revenue of $206.73 million during the quarter, compared to the consensus estimate of $201.35 million. Tilray Brands had a negative net margin of 156.51% and a negative return on equity of 3.31%. During the same period last year, the company earned ($0.87) earnings per share. Analysts anticipate that Tilray Brands, Inc. will post -0.58 EPS for the current year.

Insider Buying and Selling

In other Tilray Brands news, Director David G. Hopkinson sold 33,556 shares of the business’s stock in a transaction dated Tuesday, April 21st. The stock was sold at an average price of $6.94, for a total value of $232,878.64. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 0.84% of the company’s stock.

Institutional Trading of Tilray Brands

Several hedge funds have recently bought and sold shares of the stock. Hilton Head Capital Partners LLC acquired a new position in Tilray Brands in the 4th quarter worth $38,000. Essential Partners LLC boosted its stake in Tilray Brands by 110,137.5% in the 1st quarter. Essential Partners LLC now owns 8,819 shares of the company’s stock worth $57,000 after purchasing an additional 8,811 shares during the period. Engineers Gate Manager LP acquired a new position in Tilray Brands in the 4th quarter worth $126,000. Oppenheimer & Co. Inc. acquired a new position in Tilray Brands in the 3rd quarter worth $25,000. Finally, R Squared Ltd bought a new position in shares of Tilray Brands during the 1st quarter worth approximately $94,000. 9.35% of the stock is currently owned by institutional investors and hedge funds.

Tilray Brands Company Profile

Tilray Brands, Inc is a global cannabis-lifestyle and consumer packaged goods company engaged in the cultivation, production, distribution and sale of cannabis and cannabinoid-based products. The company develops and markets a diverse portfolio of branded products spanning medical cannabis, adult-use recreational products and wellness offerings. Through state-of-the-art cultivation facilities, research and development efforts, and quality control systems, Tilray Brands aims to deliver consistent, scalable products for a range of patient and consumer needs.

Tilray’s product lineup includes cannabis flower, pre-rolls, oils and tinctures, vapes, edibles and topicals, as well as hemp-derived cannabidiol (CBD) products.